This document updates the colorectal cancer (CRC) screening recommendations of the US
Multi-Society Task Force of Colorectal Cancer (MSTF), which represents the American …

Published meta-analyses indicate significant but inconsistent incident type-2 diabetes (T2D)-
dietary glycemic index (GI) and glycemic load (GL) risk ratios or risk relations (RR). It is now …

Objective The objective of this clinical practice guideline is to provide updated and new
evidence-based recommendations for the comprehensive care of persons with diabetes …

Colorectal cancer had a low incidence several decades ago. However, it has become a
predominant cancer and now accounts for approximately 10% of cancer-related mortality in …

Colorectal cancer (CRC) is the third most frequently detected type of cancer, and the second
most common cause of cancer-related mortality globally. The American Cancer Society …

Background Metabolic disorders are a hallmark feature of cancer. However, the evidence for
the causality of circulating metabolites to promote or prevent colorectal cancer (CRC) is still …

The incidence of diabetes and cancer has increased significantly in recent years.
Furthermore, there are many common risk factors for both diabetes and cancer, such as …

Several epidemiological studies have identified diabetes as a risk factor for colorectal
cancer (CRC). The potential pathophysiological mechanisms of this association include …

Purpose Metformin may have a role in reducing the incidence of colorectal cancer (CRC)
and improving survival outcome. This meta-analysis explored the effect of metformin use on …

We conducted a two-sample Mendelian randomization study to investigate the causal
associations of type 2 diabetes mellitus (T2DM) with risk of overall cancer and 22 site …